• Aapki Saheli
  • Astro Sathi
  • Business Khaskhabar
  • ifairer
  • iautoindia
2 of 5


Drug development has focused on the chaperone Hsp90 - heat shock protein 90 - because it plays a key role in assisting mutated proteins, making it an attractive cancer drug target.

However, the clinical efficacy of Hsp90 inhibitors has been disappointing, according to the study published in the Journal of Biological Chemistry. Read More...

Latest Gossips

वेबसाइट पर प्रकाशित सामग्री एवं सभी तरह के विवादों का न्याय क्षेत्र जयपुर ही रहेगा।
Copyright © 2026 Khaskhabar.com Group, All Rights Reserved